References
- Arrowsmith CH, Audia JE, Austin C, Baell J, Bennett J, Blagg J, Bountra C, Brennan PE, Brown PJ, Bunnage ME, et al. The promise and peril of chemical probes. Nat Chem Biol 2015; 11:536-41; PMID:26196764; https://doi.org/10.1038/nchembio.1867
- Brown PJ, Muller S. Open access chemical probes for epigenetic targets. Future Med Chem 2015; 7:1901-17; PMID:26397018; https://doi.org/10.4155/fmc.15.127
- Bunnage ME. Getting pharmaceutical R&D back on target. Nat Chem Biol 2011; 7:335-9; PMID:21587251; https://doi.org/10.1038/nchembio.581
- Frye SV. The art of the chemical probe. Nat Chem Biol 2010; 6:159-61; PMID:20154659; https://doi.org/10.1038/nchembio.296
- Muller S, Brown PJ. Epigenetic chemical probes. Clin Pharmacol Therap 2012; 92:689-93; PMID:23093316; https://doi.org/10.1038/clpt.2012.154
- Bamborough P, Chung CW, Demont EH, Furze RC, Bannister AJ, Che KH, Diallo H, Douault C, Grandi P, Kouzarides T, et al. A chemical probe for the ATAD2 bromodomain. Angewandte Chemie 2016; 55:11382-6; PMID:27530368; https://doi.org/10.1002/anie.201603928
- Lu J, Qian Y, Altieri M, Dong H, Wang J, Raina K, Hines J, Winkler JD, Crew AP, Coleman K, et al. Hijacking the E3 Ubiquitin Ligase cereblon to efficiently target BRD4. Chem Biol 2015; 22:755-63; PMID:26051217; https://doi.org/10.1016/j.chembiol.2015.05.009
- Mitchell LH, Drew AE, Ribich SA, Rioux N, Swinger KK, Jacques SL, Lingaraj T, Boriack-Sjodin PA, Waters NJ, Wigle TJ, et al. Aryl pyrazoles as potent inhibitors of arginine Methyltransferases: identification of the first PRMT6 tool compound. Acs Med Chem Lett 2015; 6:655-9; PMID:26101569; https://doi.org/10.1021/acsmedchemlett.5b00071
- Winter GE, Buckley DL, Paulk J, Roberts JM, Souza A, Dhe-Paganon S, Bradner JE. DRUG DEVELOPMENT. Phthalimide conjugation as a strategy for in vivo target protein degradation. Science 2015; 348:1376-81; PMID:25999370; https://doi.org/10.1126/science.aab1433
- Filippakopoulos P, Picaud S, Mangos M, Keates T, Lambert JP, Barsyte-Lovejoy D, Felletar I, Volkmer R, Müller S, Pawson T, et al. Histone recognition and large-scale structural analysis of the human bromodomain family. Cell 2012; 149:214-31; PMID:22464331; https://doi.org/10.1016/j.cell.2012.02.013
- Flynn EM, Huang OW, Poy F, Oppikofer M, Bellon SF, Tang Y, Cochran AG. A Subset of Human bromodomains recognizes butyryllysine and crotonyllysine histone peptide modifications. Structure 2015; 23:1801-14; PMID:26365797; https://doi.org/10.1016/j.str.2015.08.004
- Di Costanzo A, Del Gaudio N, Migliaccio A, Altucci L. Epigenetic drugs against cancer: an evolving landscape. Arch Toxicol 2014; 88:1651-68; PMID:25085708; https://doi.org/10.1007/s00204-014-1315-6
- Filippakopoulos P, Knapp S. Targeting bromodomains: epigenetic readers of lysine acetylation. Nat Rev Drug Dis 2014; 13:337-56; PMID:24751816; https://doi.org/10.1038/nrd4286
- Wadhwa E, Nicolaides T. Bromodomain Inhibitor Review: Bromodomain and Extra-terminal family protein inhibitors as a potential new therapy in central nervous system tumors. Cureus 2016; 8:e620; PMID:27382528; https://doi.org/10.7759/cureus.620
- Ghoshal A, Yugandhar D, Srivastava AK. BET inhibitors in cancer therapeutics: a patent review. Exp Opin Therap Patents 2016; 26:505-22; PMID:26924192; https://doi.org/10.1517/13543776.2016.1159299
- Chaidos A, Caputo V, Karadimitris A. Inhibition of bromodomain and extra-terminal proteins (BET) as a potential therapeutic approach in haematological malignancies: emerging preclinical and clinical evidence. Therap Adv Hematol 2015; 6:128-41; PMID:26137204; https://doi.org/10.1177/2040620715576662
- Jung M, Gelato KA, Fernandez-Montalvan A, Siegel S, Haendler B. Targeting BET bromodomains for cancer treatment. Epigenomics 2015; 7:487-501; PMID:26077433; https://doi.org/10.2217/epi.14.91
- Fu LL, Tian M, Li X, Li JJ, Huang J, Ouyang L, Zhang Y, Liu B. Inhibition of BET bromodomains as a therapeutic strategy for cancer drug discovery. Oncotarget 2015; 6:5501-16; PMID:25849938; https://doi.org/10.18632/oncotarget.3551
- Shi J, Vakoc CR. The mechanisms behind the therapeutic activity of BET bromodomain inhibition. Mol Cell 2014; 54:728-36; PMID:24905006; https://doi.org/10.1016/j.molcel.2014.05.016
- Lochrin SE, Price DK, Figg WD. BET bromodomain inhibitors–a novel epigenetic approach in castration-resistant prostate cancer. Cancer Biol Ther 2014; 15:1583-5; PMID:25535892; https://doi.org/10.4161/15384047.2014.962297
- Sahai V, Redig AJ, Collier KA, Eckerdt FD, Munshi HG. Targeting bet bromodomain proteins in solid tumors. Oncotarget 2016; 7(33):53997-4009; PMID:27283767; https://doi.org/10.18632/oncotarget.9804
- Hamamoto R, Nakamura Y. Dysregulation of protein methyltransferases in human cancer: An emerging target class for anticancer therapy. Cancer Sci 2016; 107:377-84; PMID:26751963; https://doi.org/10.1111/cas.12884
- Hirsch CL, Wrana JL, Dent SY. KATapulting toward pluripotency and cancer. J Mol Biol 2016; PMID:27720985; https://doi.org/10.1016/j.jmb.2016.09.023
- Arcipowski KM, Martinez CA, Ntziachristos P. Histone demethylases in physiology and cancer: a tale of two enzymes, JMJD3 and UTX. Curr Opin Genet Dev 2016; 36:59-67; PMID:27151432; https://doi.org/10.1016/j.gde.2016.03.010
- Muller S. Targeting the Bromome: are we there yet? Future Med Chem 2016; 8:1529-32; PMID:27578167; https://doi.org/10.4155/fmc-2016-0136
- Diamant G, Dikstein R. Transcriptional control by NF-kappaB: elongation in focus. Biochim Et Biophys Acta 2013; 1829:937-45; PMID:23624258; https://doi.org/10.1016/j.bbagrm.2013.04.007
- Choi CS, Hong SH, Sim S, Cho KS, Kim JW, Yang SM, Jeon SJ, You JS, Shin CY. The epigenetic reader BRD2 as a specific modulator of PAI-1 expression in lipopolysaccharide-stimulated mouse primary astrocytes. Neurochem Res 2015; 40:2211-9; PMID:26349765; https://doi.org/10.1007/s11064-015-1710-2
- Alsarraj J, Faraji F, Geiger TR, Mattaini KR, Williams M, Wu J, Ha NH, Merlino T, Walker RC, Bosley AD, et al. BRD4 short isoform interacts with RRP1B, SIPA1 and components of the LINC complex at the inner face of the nuclear membrane. PloS One 2013; 8:e80746; PMID:24260471; https://doi.org/10.1371/journal.pone.0080746
- Wu SY, Lee AY, Lai HT, Zhang H, Chiang CM. Phospho switch triggers Brd4 chromatin binding and activator recruitment for gene-specific targeting. Mol Cell 2013; 49:843-57; PMID:23317504; https://doi.org/10.1016/j.molcel.2012.12.006
- Zou Z, Huang B, Wu X, Zhang H, Qi J, Bradner J, Nair S, Chen LF. Brd4 maintains constitutively active NF-kappaB in cancer cells by binding to acetylated RelA. Oncogene 2014; 33:2395-404; PMID:23686307; https://doi.org/10.1038/onc.2013.179
- Suarez-Alvarez B, Morgado-Pascual JL, Rayego-Mateos S, Rodriguez RM, Rodrigues-Diez R, Cannata-Ortiz P, Sanz AB, Egido J, Tharaux PL, Ortiz A, et al. Inhibition of bromodomain and extraterminal domain family proteins ameliorates experimental renal damage. J Am Soc Nephrol 2016; PMID:27436852; https://doi.org/10.1681/ASN.2015080910
- Brown JD, Lin CY, Duan Q, Griffin G, Federation AJ, Paranal RM, Bair S, Newton G, Lichtman AH, Kung AL, et al. NF-kappaB directs dynamic super enhancer formation in inflammation and atherogenesis. Mol Cell 2014; 56:219-31; PMID:25263595; https://doi.org/10.1016/j.molcel.2014.08.024
- Duan Q, Mao X, Xiao Y, Liu Z, Wang Y, Zhou H, Zhou Z, Cai J, Xia K, Zhu Q, et al. Super enhancers at the miR-146a and miR-155 genes contribute to self-regulation of inflammation. Biochim Et Biophy Acta 2016; 1859:564-71; PMID:26855180; https://doi.org/10.1016/j.bbagrm.2016.02.004
- Yang Z, Yik JH, Chen R, He N, Jang MK, Ozato K, Zhou Q. Recruitment of P-TEFb for stimulation of transcriptional elongation by the bromodomain protein Brd4. Mol Cell 2005; 19:535-45; PMID:16109377; https://doi.org/10.1016/j.molcel.2005.06.029
- Loven J, Hoke HA, Lin CY, Lau A, Orlando DA, Vakoc CR, Bradner JE, Lee TI, Young RA. Selective inhibition of tumor oncogenes by disruption of super-enhancers. Cell 2013; 153:320-34; PMID:23582323; https://doi.org/10.1016/j.cell.2013.03.036
- Yoshida H, Bansal K, Schaefer U, Chapman T, Rioja I, Proekt I, Anderson MS, Prinjha RK, Tarakhovsky A, Benoist C, et al. Brd4 bridges the transcriptional regulators, Aire and P-TEFb, to promote elongation of peripheral-tissue antigen transcripts in thymic stromal cells. Proc Nat Acad Sci U S A 2015; 112:E4448-57; PMID:26216992; https://doi.org/10.1073/pnas.1512081112
- Ghari F, Quirke AM, Munro S, Kawalkowska J, Picaud S, McGouran J, Subramanian V, Muth A, Williams R, Kessler B, et al. Citrullination-acetylation interplay guides E2F-1 activity during the inflammatory response. Sci Adv 2016; 2:e1501257; PMID:26989780
- Nicodeme E, Jeffrey KL, Schaefer U, Beinke S, Dewell S, Chung CW, Chandwani R, Marazzi I, Wilson P, Coste H, et al. Suppression of inflammation by a synthetic histone mimic. Nature 2010; 468:1119-23; PMID:21068722; https://doi.org/10.1038/nature09589
- Ferri E, Petosa C, McKenna CE. Bromodomains: Structure, function and pharmacology of inhibition. Biochem Pharmacol 2016; 106:1-18; PMID:26707800; https://doi.org/10.1016/j.bcp.2015.12.005
- Zhang QG, Qian J, Zhu YC. Targeting bromodomain-containing protein 4 (BRD4) benefits rheumatoid arthritis. Immunol Lett 2015; 166:103-8; PMID:26093279; https://doi.org/10.1016/j.imlet.2015.05.016
- Xiao Y, Liang L, Huang M, Qiu Q, Zeng S, Shi M, Zou Y, Ye Y, Yang X, Xu H. Bromodomain and extra-terminal domain bromodomain inhibition prevents synovial inflammation via blocking IkappaB kinase-dependent NF-kappaB activation in rheumatoid fibroblast-like synoviocytes. Rheumatology 2016; 55:173-84; PMID:26324948; https://doi.org/10.1093/rheumatology/kev312
- Meng S, Zhang L, Tang Y, Tu Q, Zheng L, Yu L, Murray D, Cheng J, Kim SH, Zhou X, et al. BET inhibitor JQ1 blocks inflammation and bone destruction. J Dental Res 2014; 93:657-62; PMID:24799421; https://doi.org/10.1177/0022034514534261
- Baud'huin M, Lamoureux F, Jacques C, Rodriguez Calleja L, Quillard T, Charrier C, Amiaud J, Berreur M, Brounais-LeRoyer B, Owen R, et al. Inhibition of BET proteins and epigenetic signaling as a potential treatment for osteoporosis. Bone 2016; 94:10-21; PMID:27669656; https://doi.org/10.1016/j.bone.2016.09.020
- Bandukwala HS, Gagnon J, Togher S, Greenbaum JA, Lamperti ED, Parr NJ, Molesworth AM, Smithers N, Lee K, Witherington J, et al. Selective inhibition of CD4+ T-cell cytokine production and autoimmunity by BET protein and c-Myc inhibitors. Proc Natl Acad Sci USA 2012; 109:14532-7; PMID:22912406; https://doi.org/10.1073/pnas.1212264109
- Mele DA, Salmeron A, Ghosh S, Huang HR, Bryant BM, Lora JM. BET bromodomain inhibition suppresses TH17-mediated pathology. J Exp Med 2013; 210:2181-90; PMID:24101376; https://doi.org/10.1084/jem.20130376
- Kagoya Y, Nakatsugawa M, Yamashita Y, Ochi T, Guo T, Anczurowski M, Saso K, Butler MO, Arrowsmith CH, Hirano N. BET bromodomain inhibition enhances T cell persistence and function in adoptive immunotherapy models. J Clin Invest 2016; 126:3479-94; PMID:27548527; https://doi.org/10.1172/JCI86437
- Toniolo PA, Liu S, Yeh JE, Moraes-Vieira PM, Walker SR, Vafaizadeh V, Barbuto JA, Frank DA. Inhibiting STAT5 by the BET bromodomain inhibitor JQ1 disrupts human dendritic cell maturation. J Immunol 2015; 194:3180-90; PMID:25725100; https://doi.org/10.4049/jimmunol.1401635
- Sun Y, Wang Y, Toubai T, Oravecz-Wilson K, Liu C, Mathewson N, Wu J, Rossi C, Cummings E, Wu D, et al. BET bromodomain inhibition suppresses graft-versus-host disease after allogeneic bone marrow transplantation in mice. Blood 2015; 125:2724-8; PMID:25778533; https://doi.org/10.1182/blood-2014-08-598037
- Clifford RL, Patel JK, John AE, Tatler AL, Mazengarb L, Brightling CE, Knox AJ. CXCL8 histone H3 acetylation is dysfunctional in airway smooth muscle in asthma: regulation by BET. Am J Physiol Lung Cell Mol Physiol 2015; 308:L962-72; PMID:25713319; https://doi.org/10.1152/ajplung.00021.2015
- Kokkola T, Suuronen T, Pesonen M, Filippakopoulos P, Salminen A, Jarho EM, Lahtela-Kakkonen M. BET inhibition upregulates SIRT1 and Alleviates inflammatory responses. Chembioch Eur J Chem Biol 2015; 16:1997-2001; PMID:26212199; https://doi.org/10.1002/cbic.201500272
- Tang X, Peng R, Phillips JE, Deguzman J, Ren Y, Apparsundaram S, Luo Q, Bauer CM, Fuentes ME, DeMartino JA, et al. Assessment of Brd4 inhibition in idiopathic pulmonary fibrosis lung fibroblasts and in vivo models of lung fibrosis. Am J Pathol 2013; 183:470-79; PMID:23759512; https://doi.org/10.1016/j.ajpath.2013.04.020
- Nadeem A, Al-Harbi NO, Al-Harbi MM, El-Sherbeeny AM, Ahmad SF, Siddiqui N, Ansari MA, Zoheir KM, Attia SM, Al-Hosaini KA, et al. Imiquimod-induced psoriasis-like skin inflammation is suppressed by BET bromodomain inhibitor in mice through RORC/IL-17A pathway modulation. Pharmacological Research 2015; 99:248-57; PMID:26149470; https://doi.org/10.1016/j.phrs.2015.06.001
- Chen K, Campfield BT, Wenzel SE, McAleer JP, Kreindler JL, Kurland G, Gopal R, Wang T, Chen W, Eddens T, et al. Antiinflammatory effects of bromodomain and extraterminal domain inhibition in cystic fibrosis lung inflammation. JCI insight 2016; 1(11)e87168; PMID:27517095; https://doi.org/10.1172/jci.insight.87168
- Peeters JG, Vervoort SJ, Tan SC, Mijnheer G, de Roock S, Vastert SJ, Nieuwenhuis EE, van Wijk F, Prakken BJ, Creyghton MP, et al. Inhibition of super-enhancer activity in autoinflammatory site-derived T Cells reduces disease-associated gene expression. Cell Rep 2015; 12:1986-96; PMID:26387944; https://doi.org/10.1016/j.celrep.2015.08.046
- Wei S, Sun Y, Sha H. Therapeutic targeting of BET protein BRD4 delays murine lupus. Inter Immunopharmacol 2015; 29:314-9; PMID:26590112; https://doi.org/10.1016/j.intimp.2015.10.036
- Mahdi H, Fisher BA, Källberg H, Plant D, Malmström V, Rönnelid J, Charles P, Ding B, Alfredsson L, Padyukov L, et al. Specific interaction between genotype, smoking and autoimmunity to citrullinated alpha-enolase in the etiology of rheumatoid arthritis. Nat Gen 2009; 41:1319-24; PMID:19898480; https://doi.org/10.1038/ng.480
- Belkina AC, Nikolajczyk BS, Denis GV. BET protein function is required for inflammation: Brd2 genetic disruption and BET inhibitor JQ1 impair mouse macrophage inflammatory responses. J Immunol 2013; 190:3670-8; PMID:23420887; https://doi.org/10.4049/jimmunol.1202838
- Chen J, Wang Z, Hu X, Chen R, Romero-Gallo J, Peek RM, Jr, Chen LF. BET inhibition attenuates helicobacter pylori-induced inflammatory response by suppressing inflammatory gene transcription and enhancer activation. J Immunol 2016; 196:4132-42; PMID:27084101; https://doi.org/10.4049/jimmunol.1502261
- Philpott M, Yang J, Tumber T, Fedorov O, Uttarkar S, Filippakopoulos P, Picaud S, Keates T, Felletar I, Ciulli A, et al. Bromodomain-peptide displacement assays for interactome mapping and inhibitor discovery. Mol Biosys 2011; 7:2899-908; PMID:21804994; https://doi.org/10.1039/c1mb05099k
- Hammitzsch A, Tallant C, Fedorov O, O'Mahony A, Brennan PE, Hay DA, Martinez FO, Al-Mossawi MH, de Wit J, Vecellio M, et al. CBP30, a selective CBP/p300 bromodomain inhibitor, suppresses human Th17 responses. Proc Nat Acad Sci U S A 2015; 112:10768-73; PMID:26261308; https://doi.org/10.1073/pnas.1501956112
- Ghosh S, Taylor A, Chin M, Huang HR, Conery AR, Mertz JA, Salmeron A, Dakle PJ, Mele D, Cote A, et al. Regulatory T cell modulation by CBP/EP300 bromodomain inhibition. J Biol Chem 2016; 291:13014-27; PMID:27056325; https://doi.org/10.1074/jbc.M115.708560
- Humphreys PG, Bamborough P, Chung CW, Craggs PD, Gordon L, Grandi P, Hayhow TG, Hussain J, Jones KL, Lindon M, et al. Discovery of a potent, cell penetrant and selective p300/CBP-associated factor (PCAF)/General Control Non-Derepressible 5 (GCN5) Bromodomain chemical probe. J Med Chem 2016; 60(2):695-709; PMID:28002667; https://doi.org/10.1021/acs.jmedchem.6b01566
- Moustakim M, Clark PG, Trulli L, Fuentes de Arriba AL, Ehebauer MT, Chaikuad A, Murphy EJ, Mendez-Johnson J, Daniels D, Hou CD, et al. Discovery of a PCAF Bromodomain chemical probe. Angewandte Chemie 2017; 56(3):827-31; PMID:27966810; https://doi.org/10.1002/anie.201610816
- Theodoulou NH, Bamborough P, Bannister AJ, Becher I, Bit RA, Che KH, Chung CW, Dittmann A, Drewes G, Drewry DH, et al. Discovery of I-BRD9, a selective cell active chemical probe for bromodomain containing protein 9 inhibition. J Med Chem 2016; 59:1425-39; PMID:25856009; https://doi.org/10.1021/acs.jmedchem.5b00256
- Zhao R, Liu Y, Wang H, Yang J, Niu W, Fan S, Xiong W, Ma J, Li X, Phillips JB, et al. BRD7 plays an anti-inflammatory role during early acute inflammation by inhibiting activation of the NF-small ka, CyrillicB signaling pathway. Cell Mol Immunol 2016; 13:1-12; PMID:27374794; https://doi.org/10.1038/cmi.2016.31
- Shen Y, Szewczyk MM, Eram MS, Smil D, Kaniskan HÜ, Ferreira de Freitas R, Senisterra G, Li F, Schapira M, Brown PJ, et al. Discovery of a potent, selective, and cell-active dual inhibitor of Protein Arginine Methyltransferase 4 and protein arginine Methyltransferase 6. J Med Chem 2016; 59:9124-39; PMID:27584694; https://doi.org/10.1021/acs.jmedchem.6b01033
- Dimitrova E, Turberfield AH, Klose RJ. Histone demethylases in chromatin biology and beyond. EMBO Rep 2015; 16:1620-39; PMID:26564907; https://doi.org/10.15252/embr.201541113
- Kruidenier L, Chung CW, Cheng Z, Liddle J, Che K, Joberty G, Bantscheff M, Bountra C, Bridges A, Diallo H, et al. A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response. Nature 2012; 488:404-8; PMID:22842901; https://doi.org/10.1038/nature11262
- Yang XP, Jiang K, Hirahara K, Vahedi G, Afzali B, Sciume G, Bonelli M, Sun HW, Jankovic D, Kanno Y, et al. EZH2 is crucial for both differentiation of regulatory T cells and T effector cell expansion. Sci Rep 2015; 5:10643; PMID:26090605; https://doi.org/10.1038/srep10643
- Liu Z, Cao W, Xu L, Chen X, Zhan Y, Yang Q, Liu S, Chen P, Jiang Y, Sun X, et al. The histone H3 lysine-27 demethylase Jmjd3 plays a critical role in specific regulation of Th17 cell differentiation. J Mol Cell Biol 2015; 7:505-16; PMID:25840993; https://doi.org/10.1093/jmcb/mjv022
- Tennant BR, Hurley P, Dhillon J, Gill A, Whiting C, Hoffman BG. The TrxG complex mediates cytokine induced De Novo enhancer formation in Islets. PloS One 2015; 10:e0141470; PMID:; PMID:26505193; https://doi.org/10.1371/journal.pone.0141470
- Donas C, Carrasco M, Fritz M, Prado C, Tejón G, Osorio-Barrios F, Manríquez V, Reyes P, Pacheco R, Bono MR, et al. The histone demethylase inhibitor GSK-J4 limits inflammation through the induction of a tolerogenic phenotype on DCs. J Autoimmun 2016; 75:105-17; PMID:27528513; https://doi.org/10.1016/j.jaut.2016.07.011
- Yapp C, Carr AJ, Price A, Oppermann U, Snelling SJ. H3K27me3 demethylases regulate in vitro chondrogenesis and chondrocyte activity in osteoarthritis. Arthritis Res Ther 2016; 18:158; PMID:27388528; https://doi.org/10.1186/s13075-016-1053-7
- Na J, Lee K, Na W, Shin JY, Lee MJ, Yune TY, Lee HK, Jung HS, Kim WS, Ju BG. Histone H3K27 demethylase JMJD3 in cooperation with NF-kappaB regulates keratinocyte wound healing. J Invest Dermatol 2016; 136:847-58; PMID:26802933; https://doi.org/10.1016/j.jid.2015.11.029
- Daigle SR, Olhava EJ, Therkelsen CA, Basavapathruni A, Jin L, Boriack-Sjodin PA, Allain CJ, Klaus CR, Raimondi A, Scott MP, et al. Potent inhibition of DOT1L as treatment of MLL-fusion leukemia. Blood 2013; 122:1017-25; PMID:23801631; https://doi.org/10.1182/blood-2013-04-497644
- Kruidenier L, Chung CW, Cheng Z, Liddle J, Che K, Joberty G, Bantscheff M, Bountra C, Bridges A, Diallo H, et al. Kruidenier et al. reply. Nature 2014; 514:E2; PMID:25279927; https://doi.org/10.1038/nature13689
- McAllister TE, England KS, Hopkinson RJ, Brennan PE, Kawamura A, Schofield CJ. Recent progress in Histone Demethylase Inhibitors. J Med Chem 2016; 59:1308-29; PMID:26710088; https://doi.org/10.1021/acs.jmedchem.5b01758
- Gantier MP, Stunden HJ, McCoy CE, Behlke MA, Wang D, Kaparakis-Liaskos M, Sarvestani ST, Yang YH, Xu D, Corr SC, et al. A miR-19 regulon that controls NF-kappaB signaling. Nucl Acids Res 2012; 40:8048-58; PMID:22684508; https://doi.org/10.1093/nar/gks521
- Erdogan O, Xie L, Wang L, Wu B, Kong Q, Wan Y, Chen X. Proteomic dissection of LPS-inducible, PHF8-dependent secretome reveals novel roles of PHF8 in TLR4-induced acute inflammation and T cell proliferation. Sci Rep 2016; 6:24833; PMID:27112199; https://doi.org/10.1038/srep24833
- Lewis HD, Liddle J, Coote JE, Atkinson SJ, Barker MD, Bax BD, Bicker KL, Bingham RP, Campbell M, Chen YH, et al. Inhibition of PAD4 activity is sufficient to disrupt mouse and human NET formation. Nat Chem Biol 2015; 11:189; PMID:25622091; https://doi.org/10.1038/nchembio.1735
- Alam H, Gu B, Lee MG. Histone methylation modifiers in cellular signaling pathways. Cell Mol Life Sci 2015; 72:4577-92; PMID:26305020; https://doi.org/10.1007/s00018-015-2023-y
- Lu T, Stark GR. Using sequential immunoprecipitation and mass spectrometry to identify methylation of NF-kappaB. Methods Mol Biol 2015; 1280:383-93; PMID:25736762; https://doi.org/10.1007/978-1-4939-2422-6_23
- Kim JH, Yoo BC, Yang WS, Kim E, Hong S, Cho JY. The role of protein arginine methyltransferases in inflammatory responses. Mediators Inflamm 2016; 2016:4028353; PMID:27041824; https://doi.org/10.1155/2016/4028353
- Li Y, Reddy MA, Miao F, Shanmugam N, Yee JK, Hawkins D, Ren B, Natarajan R. Role of the histone H3 lysine 4 methyltransferase, SET7/9, in the regulation of NF-kappaB-dependent inflammatory genes. Relevance to diabetes and inflammation. J Biol Chem 2008; 283:26771-81; PMID:18650421; https://doi.org/10.1074/jbc.M802800200
- Chen X, El Gazzar M, Yoza BK, McCall CE. The NF-kappaB factor RelB and histone H3 lysine methyltransferase G9a directly interact to generate epigenetic silencing in endotoxin tolerance. J Biol Chem 2009; 284:27857-65; PMID:19690169; https://doi.org/10.1074/jbc.M109.000950
- Lu T, Jackson MW, Wang B, Yang M, Chance MR, Miyagi M, Gudkov AV, Stark GR. Regulation of NF-kappaB by NSD1/FBXL11-dependent reversible lysine methylation of p65. Proc Natl Acad Sci U S A 2010; 107:46-51; PMID:20080798; https://doi.org/10.1073/pnas.0912493107
- Levy D, Kuo AJ, Chang Y, Schaefer U, Kitson C, Cheung P, Espejo A, Zee BM, Liu CL, Tangsombatvisit S, et al. Lysine methylation of the NF-kappaB subunit RelA by SETD6 couples activity of the histone methyltransferase GLP at chromatin to tonic repression of NF-kappaB signaling. Nat Immunol 2011; 12:29-36; PMID:21131967; https://doi.org/10.1038/ni.1968
- Stender JD, Pascual G, Liu W, Kaikkonen MU, Do K, Spann NJ, Boutros M, Perrimon N, Rosenfeld MG, Glass CK. Control of proinflammatory gene programs by regulated trimethylation and demethylation of histone H4K20. Mol Cell 2012; 48:28-38; PMID:22921934; https://doi.org/10.1016/j.molcel.2012.07.020
- Wei H, Wang B, Miyagi M, She Y, Gopalan B, Huang DB, Ghosh G, Stark GR, Lu T. PRMT5 dimethylates R30 of the p65 subunit to activate NF-kappaB. Proc Natl Acad Sci U S A 2013; 110:13516-21; PMID:23904475; https://doi.org/10.1073/pnas.1311784110
- Harris DP, Chandrasekharan UM, Bandyopadhyay S, Willard B, DiCorleto PE. PRMT5-Mediated Methylation of NF-kappaB p65 at Arg174 Is Required for Endothelial CXCL11 Gene Induction in Response to TNF-alpha and IFN-gamma Costimulation. PloS One 2016; 11:e0148905; PMID:26901772; https://doi.org/10.1371/journal.pone.0148905
- Fan Z, Kong X, Xia J, Wu X, Li H, Xu H, Fang M, Xu Y. The arginine methyltransferase PRMT5 regulates CIITA-dependent MHC II transcription. Biochim Et Biophys Acta 2016; 1859:687-96; PMID:26972221; https://doi.org/10.1016/j.bbagrm.2016.03.004
- Sun Q, Yang X, Zhong B, Jiao F, Li C, Li D, Lan X, Sun J, Lu S. Upregulated protein arginine methyltransferase 1 by IL-4 increases eotaxin-1 expression in airway epithelial cells and participates in antigen-induced pulmonary inflammation in rats. J Immunol 2012; 188:3506-12; PMID:22387551; https://doi.org/10.4049/jimmunol.1102635
- Park MJ, Kim DI, Lim SK, Choi JH, Kim JC, Yoon KC, Lee JB, Lee JH, Han HJ, Choi IP, et al. Thioredoxin-interacting protein mediates hepatic lipogenesis and inflammation via PRMT1 and PGC-1alpha regulation in vitro and in vivo. J Hepatol 2014; 61:1151-7; PMID:25003952; https://doi.org/10.1016/j.jhep.2014.06.032
- Sun Q, Liu L, Roth M, Tian J, He Q, Zhong B, Bao R, Lan X, Jiang C, Sun J, et al. PRMT1 upregulated by epithelial proinflammatory cytokines participates in COX2 expression in fibroblasts and chronic antigen-induced pulmonary inflammation. J Immunol 2015; 195:298-306; PMID:26026059; https://doi.org/10.4049/jimmunol.1402465
- Liu L, Sun Q, Bao R, Roth M, Zhong B, Lan X, Tian J, He Q, Li D, Sun J, et al. Specific regulation of PRMT1 expression by PIAS1 and RKIP in BEAS-2B epithelia cells and HFL-1 fibroblasts in lung inflammation. Sc Rep 2016; 6:21810; PMID:26911452; https://doi.org/10.1038/srep21810
- Reintjes A, Fuchs JE, Kremser L, Lindner HH, Liedl KR, Huber LA, Valovka T. Asymmetric arginine dimethylation of RelA provides a repressive mark to modulate TNFalpha/NF-kappaB response. Proc Natl Acad Sci U S A 2016; 113:4326-31; PMID:27051065; https://doi.org/10.1073/pnas.1522372113
- Sun Q, Liu L, Mandal J, Molino A, Stolz D, Tamm M, Lu S, Roth M. PDGF-BB induces PRMT1 expression through ERK1/2 dependent STAT1 activation and regulates remodeling in primary human lung fibroblasts. Cell Signal 2016; 28:307-15; PMID:26795953; https://doi.org/10.1016/j.cellsig.2016.01.004
- Di Lorenzo A, Yang Y, Macaluso M, Bedford MT. A gain-of-function mouse model identifies PRMT6 as a NF-kappaB coactivator. Nucleic Acid Res 2014; 42:8297-309; PMID:24939901; https://doi.org/10.1093/nar/gku530
- Xu G, Liu G, Xiong S, Liu H, Chen X, Zheng B. The histone methyltransferase Smyd2 is a negative regulator of macrophage activation by suppressing interleukin 6 (IL-6) and tumor necrosis factor alpha (TNF-alpha) production. J Biol Chem 2015; 290:5414-23; PMID:25583990; https://doi.org/10.1074/jbc.M114.610345
- Barroso M, Kao D, Blom HJ, Tavares de Almeida I, Castro R, Loscalzo J, Handy DE. S-adenosylhomocysteine induces inflammation through NFkB: A possible role for EZH2 in endothelial cell activation. Biochim Et Biophy Acta 2016; 1862:82-92; PMID:26506125; https://doi.org/10.1016/j.bbadis.2015.10.019
- Hachiya R, Shiihashi T, Shirakawa I, Iwasaki Y, Matsumura Y, Oishi Y, Nakayama Y, Miyamoto Y, Manabe I, Ochi K, et al. The H3K9 methyltransferase Setdb1 regulates TLR4-mediated inflammatory responses in macrophages. Sci Rep 2016; 6:28845; PMID:27349785; https://doi.org/10.1038/srep28845
- Comstedt P, Storgaard M, Lassen AT. The Systemic Inflammatory Response Syndrome (SIRS) in acutely hospitalised medical patients: a cohort study. Scand J Trauma Resus Emerg Med 2009; 17:67; PMID:20035633; https://doi.org/10.1186/1757-7241-17-67
- Eram MS, Shen Y, Szewczyk MM, Wu H, Senisterra G, Li F, Butler KV, Kaniskan HÜ, Speed BA, dela Seña C, et al. A potent, selective, and cell-active inhibitor of human Type I protein arginine methyltransferases. ACS Chem Biol 2016; 11:772-81; PMID:26598975; https://doi.org/10.1021/acschembio.5b00839
- Steffan JS, Bodai L, Pallos J, Poelman M, McCampbell A, Apostol BL, Kazantsev A, Schmidt E, Zhu YZ, Greenwald M, et al. Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila. Nature 2001; 413:739-43; PMID:11607033; https://doi.org/10.1038/35099568
- Klein CJ, Botuyan MV, Wu Y, Ward CJ, Nicholson GA, Hammans S, Hojo K, Yamanishi H, Karpf AR, Wallace DC, et al. Mutations in DNMT1 cause hereditary sensory neuropathy with dementia and hearing loss. Nat Gen 2011; 43:595-600; PMID:21532572; https://doi.org/10.1038/ng.830
- Winkelmann J, Lin L, Schormair B, Kornum BR, Faraco J, Plazzi G, Melberg A, Cornelio F, Urban AE, Pizza F, et al. Mutations in DNMT1 cause autosomal dominant cerebellar ataxia, deafness and narcolepsy. Hum Mol Gen 2012; 21:2205-10; PMID:22328086; https://doi.org/10.1093/hmg/dds035
- Heppner FL, Ransohoff RM, Becher B. Immune attack: the role of inflammation in Alzheimer disease. Nat Rev Neurosci 2015; 16:358-72; PMID:25991443; https://doi.org/10.1038/nrn3880
- Dong X, Tsuji J, Labadorf A, Roussos P, Chen JF, Myers RH, Akbarian S, Weng Z. The role of H3K4me3 in transcriptional regulation is altered in Huntington's disease. PloS One 2015; 10:e0144398; PMID:26636336; https://doi.org/10.1371/journal.pone.0144398
- Verma SK, Tian X, LaFrance LV, Duquenne C, Suarez DP, Newlander KA, Romeril SP, Burgess JL, Grant SW, Brackley JA, et al. Identification of potent, selective, cell-active inhibitors of the histone lysine Methyltransferase EZH2. ACS Med Chem Lett 2012; 3:1091-6; PMID:24900432; https://doi.org/10.1021/ml3003346
- Tripathy MK, McManamy ME, Burch BD, Archin NM, Margolis DM. H3K27 demethylation at the proviral promoter sensitizes latent HIV to the effects of vorinostat in Ex vivo cultures of resting CD4+ T Cells. J Virol 2015; 89:8392-405; PMID:26041287; https://doi.org/10.1128/JVI.00572-15
- Knutson SK, Wigle TJ, Warholic NM, Sneeringer CJ, Allain CJ, Klaus CR, Sacks JD, Raimondi A, Majer CR, Song J, et al. A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells. Nat Chem Biol 2012; 8:890-6; PMID:23023262; https://doi.org/10.1038/nchembio.1084
- Scaramuzzino C, Casci I, Parodi S, Lievens PM, Polanco MJ, Milioto C, Chivet M, Monaghan J, Mishra A, Badders N, et al. Protein arginine methyltransferase 6 enhances polyglutamine-expanded androgen receptor function and toxicity in spinal and bulbar muscular atrophy. Neuron 2015; 85:88-100; PMID:25569348; https://doi.org/10.1016/j.neuron.2014.12.031
- Hossein-Nezhad A, Fatemi RP, Ahmad R, Peskind ER, Zabetian CP, Hu SC, Shi M, Wahlestedt C, Zhang J, Faghihi MA. Transcriptomic profiling of extracellular RNAs present in cerebrospinal fluid identifies differentially expressed transcripts in Parkinson's disease. J Parkinson's Dis 2016; 6:109-17; PMID:26889637; https://doi.org/10.3233/JPD-150737
- Grootjans J, Kaser A, Kaufman RJ, Blumberg RS. The unfolded protein response in immunity and inflammation. Nat Rev Immunol 2016; 16:469-84; PMID:27346803; https://doi.org/10.1038/nri.2016.62
- Moreno JA, Halliday M, Molloy C, Radford H, Verity N, Axten JM, Ortori CA, Willis AE, Fischer PM, Barrett DA, et al. Oral treatment targeting the unfolded protein response prevents neurodegeneration and clinical disease in prion-infected mice. Sci Transl Med 2013; 5:206ra138; PMID:24107777; https://doi.org/10.1126/scitranslmed.300676
- Todd DJ, Lee AH, Glimcher LH. The endoplasmic reticulum stress response in immunity and autoimmunity. Nat Rev Immunol 2008; 8:663-74; PMID:18670423; https://doi.org/10.1038/nri2359
- Zhang K, Kaufman RJ. From endoplasmic-reticulum stress to the inflammatory response. Nature 2008; 454:455-62; PMID:18650916; https://doi.org/10.1038/nature07203
- Yu W, Chory EJ, Wernimont AK, Tempel W, Scopton A, Federation A, Marineau JJ, Qi J, Barsyte-Lovejoy D, Yi J, et al. Catalytic site remodelling of the DOT1L methyltransferase by selective inhibitors. Nat Communicat 2012; 3:1288; PMID:23250418; https://doi.org/10.1038/ncomms2304
- Roidl D, Hellbach N, Bovio PP, Villarreal A, Heidrich S, Nestel S, Grüning BA, Boenisch U, Vogel T. DOT1L Activity promotes proliferation and protects cortical neural stem cells from activation of ATF4-DDIT3-Mediated ER stress In vitro. Stem Cells 2016; 34:233-45; PMID:26299268; https://doi.org/10.1002/stem.2187
- Suarez-Calvet M, Neumann M, Arzberger T, Abou-Ajram C, Funk E, Hartmann H, Edbauer D, Kremmer E, Göbl C, Resch M, et al. Monomethylated and unmethylated FUS exhibit increased binding to Transportin and distinguish FTLD-FUS from ALS-FUS. Acta Neuropathologica 2016; 131:587-604; PMID:26895297; https://doi.org/10.1007/s00401-016-1544-2
- Tibshirani M, Tradewell ML, Mattina KR, Minotti S, Yang W, Zhou H, Strong MJ, Hayward LJ, Durham HD. Cytoplasmic sequestration of FUS/TLS associated with ALS alters histone marks through loss of nuclear protein arginine methyltransferase 1. Hum Mol Gen 2015; 24:773-86; PMID:25274782; https://doi.org/10.1093/hmg/ddu494
- Kim HJ, Jeong MH, Kim KR, Jung CY, Lee SY, Kim H, Koh J, Vuong TA, Jung S, Yang H, et al. Protein arginine methylation facilitates KCNQ channel-PIP2 interaction leading to seizure suppression. eLife 2016; 5:e17159; PMID:27466704; https://doi.org/10.7554/eLife.17159
- Wright KL, Ting JP. Epigenetic regulation of MHC-II and CIITA genes. Trend Immunol 2006; 27:405-12; PMID:16870508; https://doi.org/10.1016/j.it.2006.07.007
- Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007; 448:427-34; PMID:17653185; https://doi.org/10.1038/nature06005
- Antignano F, Burrows K, Hughes MR, Han JM, Kron KJ, Penrod NM, Oudhoff MJ, Wang SK, Min PH, Gold MJ, et al. Methyltransferase G9A regulates T cell differentiation during murine intestinal inflammation. J Clin Invest 2014; 124:1945-55; PMID:24667637; https://doi.org/10.1172/JCI69592
- Nakanishi Y, Reina-Campos M, Nakanishi N, Llado V, Elmen L, Peterson S, Campos A, De SK, Leitges M, Ikeuchi H, et al. Control of Paneth cell fate, intestinal inflammation, and tumorigenesis by PKClambda/iota. Cell Reports 2016; 16:3297-310; PMID:27653691; https://doi.org/10.1016/j.celrep.2016.08.054
- Lehnertz B, Northrop JP, Antignano F, Burrows K, Hadidi S, Mullaly SC, Rossi FM, Zaph C. Activating and inhibitory functions for the histone lysine methyltransferase G9a in T helper cell differentiation and function. J Exp Med 2010; 207:915-22; PMID:20421388; https://doi.org/10.1084/jem.20100363
- Kind J, Pagie L, Ortabozkoyun H, Boyle S, de Vries SS, Janssen H, Amendola M, Nolen LD, Bickmore WA, van Steensel B. Single-cell dynamics of genome-nuclear lamina interactions. Cell 2013; 153:178-92; PMID:23523135; https://doi.org/10.1016/j.cell.2013.02.028
- Montes de Oca R, Andreassen PR, Wilson KL. Barrier-to-Autointegration Factor influences specific histone modifications. Nucleus 2011; 2:580-90; PMID:22127260; https://doi.org/10.4161/nucl.2.6.17960
- Vedadi M, Barsyte-Lovejoy D, Liu F, Rival-Gervier S, Allali-Hassani A, Labrie V, Wigle TJ, Dimaggio PA, Wasney GA, Siarheyeva A, et al. A chemical probe selectively inhibits G9a and GLP methyltransferase activity in cells. Nat Chem Biol 2011; 7:566-74; PMID:21743462; https://doi.org/10.1038/nchembio.599
- Kubicek S, O'Sullivan RJ, August EM, Hickey ER, Zhang Q, Teodoro ML, Rea S, Mechtler K, Kowalski JA, Homon CA, et al. Reversal of H3K9me2 by a small-molecule inhibitor for the G9a histone methyltransferase. Mol Cell 2007; 25:473-81; PMID:17289593; https://doi.org/10.1016/j.molcel.2007.01.017
- Cadwell K, Liu JY, Brown SL, Miyoshi H, Loh J, Lennerz JK, Kishi C, Kc W, Carrero JA, Hunt S, et al. A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells. Nat 2008; 456:259-63; PMID:18849966; https://doi.org/10.1038/nature07416
- Wu SC, Zhang Y. Cyclin-dependent kinase 1 (CDK1)-mediated phosphorylation of enhancer of zeste 2 (Ezh2) regulates its stability. J Biol Chem 2011; 286:28511-9; PMID:21659531; https://doi.org/10.1074/jbc.M111.240515
- Koppens MA, Bounova G, Gargiulo G, Tanger E, Janssen H, Cornelissen-Steijger P, Blom M, Song JY, Wessels LF, van Lohuizen M. Deletion of polycomb repressive Complex 2 from mouse intestine causes loss of stem cells. Gastroenterol 2016; 151:684-97 e612; PMID:27342214; https://doi.org/10.1053/j.gastro.2016.06.020
- Taube R, Peterlin M. Lost in transcription: molecular mechanisms that control HIV latency. Viruses 2013; 5:902-27; PMID:23518577; https://doi.org/10.3390/v5030902
- Polizzotto MN, Chen G, Tressler RL, Godfrey C. Leveraging Cancer Therapeutics for the HIV Cure Agenda: current status and future directions. Drugs 2015; 75:1447-59; PMID:26224205; https://doi.org/10.1007/s40265-015-0426-6
- Banerjee C, Archin N, Michaels D, Belkina AC, Denis GV, Bradner J, Sebastiani P, Margolis DM, Montano M. BET bromodomain inhibition as a novel strategy for reactivation of HIV-1. J Leukocyte Biol 2012; 92:1147-54; PMID:22802445; https://doi.org/10.1189/jlb.0312165
- Jiang G, Mendes EA, Kaiser P, Sankaran-Walters S, Tang Y, Weber MG, Melcher GP, Thompson GR 3rd, Tanuri A, Pianowski LF, et al. Reactivation of HIV latency by a newly modified Ingenol derivative via protein kinase Cdelta-NF-kappaB signaling. Aids 2014; 28:1555-66; PMID:24804860; https://doi.org/10.1097/QAD.0000000000000289
- Jiang G, Mendes EA, Kaiser P, Wong DP, Tang Y, Cai I, Fenton A, Melcher GP, Hildreth JE, Thompson GR, et al. Synergistic reactivation of latent HIV expression by Ingenol-3-Angelate, PEP005, Targeted NF-kB signaling in combination with JQ1 Induced p-TEFb activation. PLoS Pathogens 2015; 11:e1005066; PMID:26225771; https://doi.org/10.1371/journal.ppat.1005066
- Darcis G, Kula A, Bouchat S, Fujinaga K, Corazza F, Ait-Ammar A, Delacourt N, Melard A, Kabeya K, Vanhulle C, et al. An In-Depth comparison of latency-reversing agent combinations in various in Vitro and Ex Vivo HIV-1 Latency Models Identified Bryostatin-1+JQ1 and Ingenol-B+JQ1 to potently reactivate viral gene expression. PLoS Pathogens 2015; 11:e1005063; PMID:26225566; https://doi.org/10.1371/journal.ppat.1005063
- Lu P, Qu X, Shen Y, Jiang Z, Wang P, Zeng H, Ji H, Deng J, Yang X, Li X, et al. The BET inhibitor OTX015 reactivates latent HIV-1 through P-TEFb. Sci Rep 2016; 6:24100; PMID:27067814; https://doi.org/10.1038/srep24100
- Boehm D, Calvanese V, Dar RD, Xing S, Schroeder S, Martins L, Aull K, Li PC, Planelles V, Bradner JE, et al. BET bromodomain-targeting compounds reactivate HIV from latency via a Tat-independent mechanism. Cell Cycle 2013; 12:452-62; PMID:23255218; https://doi.org/10.4161/cc.23309
- Zhang HS, Du GY, Liu Y, Zhang ZG, Zhou Z, Li H, Dai KQ, Yu XY, Gou XM. UTX-1 regulates Tat-induced HIV-1 transactivation via changing the methylated status of histone H3. Inter J Biochem Cell Biol 2016; 80:51-56; PMID:27671333; https://doi.org/10.1016/j.biocel.2016.09.016
- Messer HG, Jacobs D, Dhummakupt A, Bloom DC. Inhibition of H3K27me3-specific histone demethylases JMJD3 and UTX blocks reactivation of herpes simplex virus 1 in trigeminal ganglion neurons. J Virol 2015; 89:3417-20; PMID:25552720; https://doi.org/10.1128/JVI.03052-14
- Imai K, Togami H, Okamoto T. Involvement of histone H3 lysine 9 (H3K9) methyltransferase G9a in the maintenance of HIV-1 latency and its reactivation by BIX01294. J Biol Chem 2010; 285:16538-45; PMID:20335163; https://doi.org/10.1074/jbc.M110.103531
- Friedman J, Cho WK, Chu CK, Keedy KS, Archin NM, Margolis DM, Karn J. Epigenetic silencing of HIV-1 by the histone H3 lysine 27 methyltransferase enhancer of Zeste 2. J Virol 2011; 85:9078-89; PMID:21715480; https://doi.org/10.1128/JVI.00836-11
- Matsuda Y, Kobayashi-Ishihara M, Fujikawa D, Ishida T, Watanabe T, Yamagishi M. Epigenetic heterogeneity in HIV-1 latency establishment. Sci Rep 2015; 5:7701; PMID:25572573; https://doi.org/10.1038/srep07701
- Fulcher AJ, Jans DA. The HIV-1 Tat transactivator protein: a therapeutic target? IUBMB Life 2003; 55:669-80; PMID:14769003; https://doi.org/10.1080/15216540310001643440
- Mizutani T, Ishizaka A, Tomizawa M, Okazaki T, Yamamichi N, Kawana-Tachikawa A, Iwamoto A, Iba H. Loss of the Brm-type SWI/SNF chromatin remodeling complex is a strong barrier to the Tat-independent transcriptional elongation of human immunodeficiency virus type 1 transcripts. J Virol 2009; 83:11569-80; PMID:19726504; https://doi.org/10.1128/JVI.00742-09
- Sivakumaran H, van der Horst A, Fulcher AJ, Apolloni A, Lin MH, Jans DA, Harrich D. Arginine methylation increases the stability of human immunodeficiency virus type 1 Tat. J Virol 2009; 83:11694-703; PMID:19726520; https://doi.org/10.1128/JVI.00499-09
- Xie B, Invernizzi CF, Richard S, Wainberg MA. Arginine methylation of the human immunodeficiency virus type 1 Tat protein by PRMT6 negatively affects Tat Interactions with both cyclin T1 and the Tat transactivation region. J Virol 2007; 81:4226-34; PMID:17267505; https://doi.org/10.1128/JVI.01888-06
- Sivakumaran H, Lin MH, Apolloni A, Cutillas V, Jin H, Li D, Wei T, Harrich D. Overexpression of PRMT6 does not suppress HIV-1 Tat transactivation in cells naturally lacking PRMT6. Virol J 2013; 10:207; PMID:23800116; https://doi.org/10.1186/1743-422X-10-207
- Church ME, Estrada M, Leutenegger CM, Dela Cruz FN, Pesavento PA, Woolard KD. BRD4 is associated with Raccoon Polyomavirus (RacPyV) genome and mediates viral gene transcription and maintenance of a stem cell state in neuroglial tumor cells. J Gen Virol 2016; 97:2939-48; PMID:27600312; https://doi.org/10.1099/jgv.0.000594
- Wollebo HS, Bellizzi A, Cossari DH, Salkind J, Safak M, White MK. The Brd4 acetyllysine-binding protein is involved in activation of polyomavirus JC. J Neurovirol 2016; 22(5):615-25; PMID:27007123; https://doi.org/10.1007/s13365-016-0435-6
- Zhou H, Schmidt SC, Jiang S, Willox B, Bernhardt K, Liang J, Johannsen EC, Kharchenko P, Gewurz BE, Kieff E, et al. Epstein-Barr virus oncoprotein super-enhancers control B cell growth. Cell Host Microb 2015; 17:205-16; PMID:25639793; https://doi.org/10.1016/j.chom.2014.12.013
- Palermo RD, Webb HM, West MJ. RNA polymerase II stalling promotes nucleosome occlusion and pTEFb recruitment to drive immortalization by Epstein-Barr virus. PLoS Pathogens 2011; 7:e1002334; PMID:22046134; https://doi.org/10.1371/journal.ppat.1002334
- Chang SW, Liu WC, Liao KY, Tsao YP, Hsu PH, Chen SL. Phosphorylation of HPV-16 E2 at serine 243 enables binding to Brd4 and mitotic chromosomes. PloS One 2014; 9:e110882; PMID:25340539; https://doi.org/10.1371/journal.pone.0110882
- Helfer CM, Yan J, You J. The cellular bromodomain protein Brd4 has multiple functions in E2-mediated papillomavirus transcription activation. Viruses 2014; 6:3228-49; PMID:25140737; https://doi.org/10.3390/v6083228
- Wang X, Helfer CM, Pancholi N, Bradner JEM, You J. Recruitment of Brd4 to the human papillomavirus type 16 DNA replication complex is essential for replication of viral DNA. J Virol 2013; 87:3871-84; PMID:23365439; https://doi.org/10.1128/JVI.03068-12
- Jung GS, Jeon JH, Choi YK, Jang SY, Park SY, Kim SW, Byun JK, Kim MK, Lee S, Shin EC, et al. Pyruvate dehydrogenase kinase regulates hepatitis C virus replication. Sci Rep 2016; 6:30846; PMID:27471054; https://doi.org/10.1038/srep30846
- Wang X, Li J, Schowalter RM, Jiao J, Buck CB, You J. Bromodomain protein Brd4 plays a key role in Merkel cell polyomavirus DNA replication. PLoS Pathogens 2012; 8:e1003021; PMID:23144621; https://doi.org/10.1371/journal.ppat.1003021
- Sharma A, Larue RC, Plumb MR, Malani N, Male F, Slaughter A, Kessl JJ, Shkriabai N, Coward E, Aiyer SS, et al. BET proteins promote efficient murine leukemia virus integration at transcription start sites. Proc Nat Acad Sci U S A 2013; 110:12036-41; PMID: 23818621; https://doi.org/10.1073/pnas.1307157110
- Gupta SS, Maetzig T, Maertens GN, Sharif A, Rothe M, Weidner-Glunde M, Galla M, Schambach A, Cherepanov P, Schulz TF. Bromo- and extraterminal domain chromatin regulators serve as cofactors for murine leukemia virus integration. J Virol 2013; 87:12721-36; PMID:24049186; https://doi.org/10.1128/JVI.01942-13
- Thomas M, Sonntag E, Müller R, Schmidt S, Zielke B, Fossen T, Stamminger T. pUL69 of human cytomegalovirus recruits the cellular protein Arginine Methyltransferase 6 via a domain that is crucial for mRNA export and efficient viral replication. J Virol 2015; 89:9601-15; PMID:26178996; https://doi.org/10.1128/JVI.01399-15
- Friedrich S, Schmidt T, Schierhorn A, Lilie H, Szczepankiewicz G, Bergs S, Liebert UG, Golbik RP, Behrens SE. Arginine methylation enhances the RNA chaperone activity of the West Nile virus host factor AUF1 p45. Rna 2016; 22:1574-91; PMID:27520967; https://doi.org/10.1261/rna.055269.115
- Han T, Wan Y, Wang J, Zhao P, Yuan Y, Wang L, She Y, Broering R, Lu M, Ye L, et al. Set7 facilitates hepatitis C virus replication via enzymatic activity-dependent attenuation of the IFN-related pathway. J Immunol 2015; 194:2757-68; PMID:25681344; https://doi.org/10.4049/jimmunol.1400583
- Wang Y, Zhong H, Xie X, Chen CY, Huang D, Shen L, Zhang H, Chen ZW, Zeng G. Long noncoding RNA derived from CD244 signaling epigenetically controls CD8+ T-cell immune responses in tuberculosis infection. Proc Natl Acad Sci U S A 2015; 112:E3883-92; PMID:26150504; https://doi.org/10.1073/pnas.1501662112
- Ciccarelli M, Vastolo V, Albano L, Lecce M, Cabaro S, Liotti A, Longo M, Oriente F, Russo GL, Macchia PE, et al. Glucose-induced expression of the homeotic transcription factor Prep1 is associated with histone post-translational modifications in skeletal muscle. Diabetologia 2016; 59:176-86; PMID:26453063; https://doi.org/10.1007/s00125-015-3774-6
- Goru SK, Kadakol A, Pandey A, Malek V, Sharma N, Gaikwad AB. Histone H2AK119 and H2BK120 mono-ubiquitination modulate SET7/9 and SUV39H1 in type 1 diabetes-induced renal fibrosis. Biochem J 2016; 473:3937-49; PMID:27582499; https://doi.org/10.1042/BCJ20160595
- Yuan H, Reddy MA, Deshpande S, Jia Y, Park JT, Lanting LL, Jin W, Kato M, Xu ZG, Das S. Epigenetic histone modifications involved in profibrotic gene regulation by 12/15-Lipoxygenase and its oxidized lipid products in diabetic nephropathy. Antioxid Redox Signal 2016; 24:361-75; PMID:26492974; https://doi.org/10.1089/ars.2015.6372
- Paneni F, Costantino S, Battista R, Castello L, Capretti G, Chiandotto S, Scavone G, Villano A, Pitocco D, Lanza G, et al. Adverse epigenetic signatures by histone methyltransferase Set7 contribute to vascular dysfunction in patients with type 2 diabetes mellitus. Circ Cardiovasc Gen 2015; 8:150-8; PMID:25472959; https://doi.org/10.1161/CIRCGENETICS.114.000671
- Maganti AV, Maier B, Tersey SA, Sampley ML, Mosley AL, Özcan S, Pachaiyappan B, Woster PM, Hunter CS, Stein R, et al. Transcriptional activity of the islet beta cell factor Pdx1 is augmented by lysine methylation catalyzed by the methyltransferase Set7/9. J Biol Chem 2015; 290:9812-22; PMID:25713082; https://doi.org/10.1074/jbc.M114.616219
- Son MJ, Kim WK, Oh KJ, Park A, Lee da S, Han BS, Lee SC, Bae KH. Methyltransferase and demethylase profiling studies during brown adipocyte differentiation. BMB Rep 2016; 49:388-93; PMID:27157542; https://doi.org/10.5483/BMBRep.2016.49.7.062
- LeBlanc SE, Wu Q, Lamba P, Sif S, Imbalzano AN. Promoter-enhancer looping at the PPARgamma2 locus during adipogenic differentiation requires the Prmt5 methyltransferase. Nucl Acid Res 2016; 44:5133-47; PMID:26935580; https://doi.org/10.1093/nar/gkw129
- Yi SA, Um SH, Lee J, Yoo JH, Bang SY, Park EK, Lee MG, Nam KH, Jeon YJ, Park JW, et al. S6K1 phosphorylation of H2B mediates EZH2 trimethylation of H3: A determinant of early adipogenesis. Mol Cell 2016; 62:443-52; PMID:27151441; https://doi.org/10.1016/j.molcel.2016.03.011
- Claycombe KJ, Vomhof-DeKrey EE, Garcia R, Johnson WT, Uthus E, Roemmich JN. Decreased beige adipocyte number and mitochondrial respiration coincide with increased histone methyl transferase (G9a) and reduced FGF21 gene expression in Sprague-Dawley rats fed prenatal low protein and postnatal high-fat diets. J Nutrit Biochem 2016; 31:113-21; PMID:27133430; https://doi.org/10.1016/j.jnutbio.2016.01.008
- Kim DI, Park MJ, Choi JH, Kim IS, Han HJ, Yoon KC, Park SW, Lee MY, Oh KS, Park SH. PRMT1 and PRMT4 regulate oxidative stress-induced retinal pigment epithelial cell damage in SIRT1-dependent and SIRT1-independent manners. Oxidat Med Cell Longev 2015; 617919; PMID:26583059; https://doi.org/10.1155/2015/617919
- Wang F, Liu H, Blanton WP, Belkina A, Lebrasseur NK, Denis GV. Brd2 disruption in mice causes severe obesity without Type 2 diabetes. Biochem J 2010; 425:71-83; PMID:19883376; https://doi.org/10.1042/BJ20090928
- Wang F, Deeney JT, Denis GV. Brd2 gene disruption causes “metabolically healthy” obesity: epigenetic and chromatin-based mechanisms that uncouple obesity from type 2 diabetes. Vitam Horm 2013; 91:49-75; PMID:23374712; https://doi.org/10.1016/B978-0-12-407766-9.00003-1
- Liu X, Chen Z, Xu C, Leng X, Cao H, Ouyang G, Xiao W. Repression of hypoxia-inducible factor alpha signaling by Set7-mediated methylation. Nucl Acid Res 2015; 43:5081-98; PMID:25897119; https://doi.org/10.1093/nar/gkv379
- Rodriguez H, Rafehi H, Bhave M, El-Osta A. Metabolism and chromatin dynamics in health and disease. Mol Aspect Med 2016; PMID:27697603; https://doi.org/10.1016/j.mam.2016.09.004
- Barsyte-Lovejoy D, Li F, Oudhoff MJ, Tatlock JH, Dong A, Zeng H, Wu H, Freeman SA, Schapira M, Senisterra GA, et al. (R)-PFI-2 is a potent and selective inhibitor of SETD7 methyltransferase activity in cells. Proc Natl Acad Sci U S A 2014; 111:12853-8; PMID:25136132; https://doi.org/10.1073/pnas.1407358111
- Han HS, Choi D, Choi S, Koo SH. Roles of protein arginine methyltransferases in the control of glucose metabolism. Endocrinol Metabol 2014; 29:435-40; PMID:25559572; https://doi.org/10.3803/EnM.2014.29.4.435
- Deeney JT, Belkina AC, Shirihai OS, Corkey BE, Denis GV. BET Bromodomain Proteins Brd2, Brd3 and Brd4 selectively regulate metabolic pathways in the Pancreatic beta-Cell. PloS One 2016; 11:e0151329; PMID:27008626; https://doi.org/10.1371/journal.pone.0151329
- Krivega I, Dale RK, Dean A. Role of LDB1 in the transition from chromatin looping to transcription activation. Gen Dev 2014; 28:1278-90; PMID:24874989; https://doi.org/10.1101/gad.239749.114
- Sunshine HR, Hofrichter J, Eaton WA. Requirement for therapeutic inhibition of sickle haemoglobin gelation. Nature 1978; 275:238-40; PMID:692700; https://doi.org/10.1038/275238a0
- Xu J, Bauer DE, Kerenyi MA, Vo TD, Hou S, Hsu YJ, Yao H, Trowbridge JJ, Mandel G, Orkin SH. Corepressor-dependent silencing of fetal hemoglobin expression by BCL11A. Proc Natl Acad Sci U S A 2013; 110:6518-23; PMID:23576758; https://doi.org/10.1073/pnas.1303976110
- Bradner JE, Mak R, Tanguturi SK, Mazitschek R, Haggarty SJ, Ross K, Chang CY, Bosco J, West N, Morse E, et al. Chemical genetic strategy identifies histone deacetylase 1 (HDAC1) and HDAC2 as therapeutic targets in sickle cell disease. Proc Natl Acad Sci U S A 2010; 107:12617-22; PMID:20616024; https://doi.org/10.1073/pnas.1006774107
- Rank G, Cerruti L, Simpson RJ, Moritz RL, Jane SM, Zhao Q. Identification of a PRMT5-dependent repressor complex linked to silencing of human fetal globin gene expression. Blood 2010; 116:1585-92; PMID:20495075; https://doi.org/10.1182/blood-2009-10-251116
- Shi L, Cui S, Engel JD, Tanabe O. Lysine-specific demethylase 1 is a therapeutic target for fetal hemoglobin induction. Nature Medicine 2013; 19:291-4; PMID:23416702; https://doi.org/10.1038/nm.3101
- Krivega I, Byrnes C, de Vasconcellos JF, Lee YT, Kaushal M, Dean A, Miller JL. Inhibition of G9a methyltransferase stimulates fetal hemoglobin production by facilitating LCR/gamma-globin looping. Blood 2015; 126:665-72; PMID:25979948; https://doi.org/10.1182/blood-2015-02-629972
- Renneville A, Van Galen P, Canver MC, McConkey M, Krill-Burger JM, Dorfman DM, Holson EB, Bernstein BE, Orkin SH, Bauer DE, et al. EHMT1 and EHMT2 inhibition induces fetal hemoglobin expression. Blood 2015; 126:1930-9; PMID:26320100; https://doi.org/10.1182/blood-2015-06-649087
- Kadoch C, Copeland RA, Keilhack H. PRC2 and SWI/SNF chromatin remodeling complexes in health and disease. Biochemistry 2016; 55:1600-14; PMID:26836503; https://doi.org/10.1021/acs.biochem.5b01191
- Fedorov O, Castex J, Tallant C, Owen DR, Martin S, Aldeghi M, Monteiro O, Filippakopoulos P, Picaud S, Trzupek JD, et al. Selective targeting of the BRG/PB1 bromodomains impairs embryonic and trophoblast stem cell maintenance. Sci Adv 2015; 1:e1500723; PMID:26702435; https://doi.org/10.1126/sciadv.1500723
- Vangamudi B, Paul TA, Shah PK, Kost-Alimova M, Nottebaum L, Shi X, Zhan Y, Leo E, Mahadeshwar HS, Protopopov A, et al. The SMARCA2/4 ATPase domain surpasses the bromodomain as a drug target in SWI/SNF-mutant cancers: insights from cDNA rescue and PFI-3 inhibitor studies. Cancer Res 2015; 75:3865-78; PMID:26139243; https://doi.org/10.1158/0008-5472.CAN-14-3798
- Gerstenberger BS, Trzupek JD, Tallant C, Fedorov O, Filippakopoulos P, Brennan PE, Fedele V, Martin S, Picaud S, Rogers C, et al. Identification of a Chemical Probe for Family VIII Bromodomains through Optimization of a Fragment Hit. J Med Chem 2016; 59:4800-11; PMID:27115555; https://doi.org/10.1021/acs.jmedchem.6b00012
- Gonzales-Cope M, Sidoli S, Bhanu NV, Won KJ, Garcia BA. Histone H4 acetylation and the epigenetic reader Brd4 are critical regulators of pluripotency in embryonic stem cells. BMC Genomics 2016; 17:95; PMID:26847871; https://doi.org/10.1186/s12864-016-2414-y
- Hofstetter C, Kampka JM, Huppertz S, Weber H, Schlosser A, Müller AM, Becker M. Inhibition of KDM6 activity during murine ESC differentiation induces DNA damage. J Cell Sc 2016; 129:788-803; PMID:26759175; https://doi.org/10.1242/jcs.175174
- Kamikawa YF, Donohoe ME. Histone demethylation maintains Prdm14 and Tsix expression and represses xIst in embryonic stem cells. Plos One 2015; 10:e0125626; PMID:25993097; https://doi.org/10.1371/journal.pone.0125626
- Kang SC, Kim SK, Chai JC, Kim SH, Won KJ, Lee YS, Jung KH, Chai YG. Transcriptomic Profiling and H3K27me3 distribution reveal both Demethylase-Dependent and independent regulation of developmental gene transcription in cell differentiation. Plos One 2015; 10:e0135276; PMID:26263556; https://doi.org/10.1371/journal.pone.0135276
- Korb E, Herre M, Zucker-Scharff I, Darnell RB, Allis CD. BET protein Brd4 activates transcription in neurons and BET inhibitor Jq1 blocks memory in mice. Nat Neurosci 2015; 18:1464-73; PMID:26301327; https://doi.org/10.1038/nn.4095
- Xu Y, Cao W, Zhou M, Li C, Luo Y, Wang H, Zhao R, Jiang S, Yang J, Liu Y, et al. Inactivation of BRD7 results in impaired cognitive behavior and reduced synaptic plasticity of the medial prefrontal cortex. Behav Brain Res 2015; 286:1-10; PMID:25721744; https://doi.org/10.1016/j.bbr.2015.02.031